The research team, led by Danhong Ge, YangYang Luo, Ruyu Zhang, Xuechao Hu, and Lujing Ren, set out to answer a deceptively simple question: what happens when you expose a microbe that normally grows in the dark to sustained light stress? Schizochytrium sp. HX-308, the strain used in the study, was isolated from seawater and deposited in the China Center for Type Culture Collection. In industrial settings it is typically fermented in large, dark vessels where it converts glucose into a lipid-rich biomass. Light, in this context, is usually treated as an irrelevance or even a nuisance. The new study suggests that assumption deserves a second look, because light turns out to be a powerful abiotic stress factor that reprograms the cell’s entire metabolic priorities.

The researchers divided the fermentation process into three distinct phases: a cell growth stage from zero to forty-eight hours, a lipid accumulation stage from forty-eight to ninety-six hours, and a lipid turnover stage from ninety-six to one hundred forty-four hours, when the cells begin consuming their own stored fat reserves. Under normal dark conditions, the culture reached a maximum cell dry weight of 50.5 grams per liter at seventy-two hours. When the flasks were illuminated with an array of LED strips delivering a total luminous flux of 18,311.4 lumens, growth slowed noticeably. Glucose consumption was delayed, the fermentation cycle stretched from seventy-two to ninety-six hours, and the peak biomass fell to 41.3 grams per liter, a reduction of 18.21 percent compared with the dark-grown control.

Microscopy revealed that the light-exposed cells were visibly different from their dark-grown counterparts. They grew larger in diameter, became more dispersed and independent in their morphology, and accumulated more prominent lipid droplets as the fermentation progressed. Using propidium iodide staining under a confocal fluorescence microscope, the team showed that cell membrane damage was consistently higher under light stress, peaking at ninety-six hours, precisely when the lipid turnover phase begins. The researchers hypothesize that the enlarged cell diameter is an adaptive response, allowing the organism to meet the elevated energy and material demands imposed by the stressful environment. Similar light-induced changes in cell size have been documented in diatoms such as Ditylum brightwellii, suggesting this may be a widespread strategy among marine microbes.

The real surprise came when the team measured what the cells were actually producing. Although the light-stressed cultures grew more slowly, their final lipid yield reached 8.45 grams per liter, a striking 39.67 percent higher than the 6.05 grams per liter measured in the control after the turnover phase had run its course. The delayed glucose consumption appears to slow the onset of lipid turnover, effectively extending the window during which the cells hold onto their oil. In other words, the stress that cost the microbe some of its growth paid off handsomely in the currency that industry actually cares about: stored lipid that survives to the end of the fermentation.

The composition of that lipid changed too, and in commercially interesting directions. Saturated fatty acids, particularly myristic acid (C14:0) and palmitic acid (C16:0), were 1.49 times more abundant in the light-treated group, reaching 4.97 percent and 15.86 percent of the total fatty acid pool respectively. Saturated fats of this kind are the raw material for neutral lipid formation and have their own market in oleochemical applications. Meanwhile, the polyunsaturated fatty acids docosapentaenoic acid and DHA declined modestly, from 24.74 percent and 59.14 percent in the control to 20.59 percent and 56.28 percent under light. But eicosapentaenoic acid, or EPA, an omega-3 fatty acid with anti-inflammatory applications and a notoriously difficult production process, jumped from 2.14 percent to 8.30 percent of total fatty acids, a 3.88-fold increase that caught the researchers’ attention.

Beyond the fatty acids, light stress proved to be a potent trigger for two of the microbe’s most valuable secondary metabolites. Squalene, a terpenoid used in cosmetics, vaccines, and pharmaceutical formulations, peaked at 67.46 milligrams per liter at seventy-two hours under light stress, compared with 55.67 milligrams per liter at forty-eight hours in the dark, and the light-stressed cultures sustained higher squalene levels through the later stages of fermentation, ending 21.17 percent above the control. Beta-carotene followed a similar pattern, peaking at roughly 7,184 micrograms per liter at ninety-six hours under light versus 5,368 micrograms per liter at seventy-two hours in the dark. By the end of fermentation, the light-stressed cultures contained 5,675 micrograms per liter of beta-carotene, 4.75 times the control level. Astaxanthin, a premium carotenoid synthesized downstream of beta-carotene, rose continuously throughout the light-stressed fermentation, finishing nearly 2,081 micrograms per liter, 11.39 percent above the control, and its accumulation only accelerated after beta-carotene had peaked, consistent with beta-carotene serving as a metabolic precursor.

To understand why light produces these effects, the team measured intracellular reactive oxygen species and performed a full transcriptomic analysis using Illumina RNA sequencing. Light stress elevated oxidative pressure inside the cells, but the light-stressed cultures actually showed lower peak ROS levels than the controls, indicating that the organism mounts a robust antioxidant defense. The transcriptome told the molecular story. A core set of 226 differentially expressed genes was shared across all light-versus-dark comparisons, while the 144-hour comparison alone revealed 788 unique light-responsive genes. At seventy-two hours, light stress predominantly suppressed metabolic genes, an acute stress response; by 144 hours, the pattern flipped to widespread upregulation, signaling a transition to long-term metabolic reprogramming. Gene ontology analysis showed marked enrichment of genes involved in stimulus response, antioxidant activity, and transporter activity under light, while genes for lipid biosynthesis and antioxidant processes became dominant at the later time point.

The pathway-level details are particularly revealing. In the mevalonate pathway, which supplies the building blocks for isoprenoids such as squalene, the enzyme isopentenyl diphosphate isomerase was significantly upregulated under light, especially at 144 hours, along with farnesyl diphosphate synthase and squalene synthase, the enzymes that assemble farnesyl diphosphate into squalene itself. Fatty acid metabolism showed a dual pattern: acetyl-CoA carboxylase and fatty acid synthase were upregulated, driving carbon toward palmitic acid, while a key beta-oxidation gene was downregulated, meaning the cells burned less of the fat they stored. Intriguingly, glycolysis genes were suppressed, suggesting the microbe rerouted carbon flux away from rapid energy production and toward lipid and terpenoid biosynthesis, a strategy that mirrors engineered lipid-boosting interventions in other microalgae. The upregulated polyketide synthase genes hint at the channeling of resources toward EPA production, which supports membrane fluidity under stress.

For the biotechnology industry, the implications are considerable. Light is an inexpensive, non-invasive, and precisely controllable stimulus compared with chemical additives or genetic engineering, and this study demonstrates that it can simultaneously raise lipid yield, enrich EPA, and boost squalene and carotenoid production in a single fermentation run. The trade-off, a longer fermentation cycle and lower biomass, is a real cost, but the researchers argue that the metabolic insights gained here, particularly the coordinated upregulation of the mevalonate pathway and the suppression of fatty acid degradation, could guide further optimization, whether through tuned light regimens, light combined with other stressors, or targeted engineering of the genes identified in the transcriptome. As demand for omega-3 oils and natural antioxidants continues to climb, the idea that a well-placed bank of LED strips could coax more value out of every liter of fermentation broth is an appealingly simple proposition, and one that this marine microbe appears ready to deliver on.

Subject of Research: Effect of light stress on lipid, fatty acid, squalene, and carotenoid biosynthesis in the marine protist Schizochytrium sp.

Article Title: Effect of light stress on the production of lipid compounds by Schizochytrium sp. and its underlying mechanism

Article References: Ge, D., Luo, Y., Zhang, R., Hu, X., & Ren, L. (2025). Effect of light stress on the production of lipid compounds by Schizochytrium sp. and its underlying mechanism. Blue Biotechnology, 2(1), Article 8. https://doi.org/10.1186/s44315-025-00029-7

Image Credits: AI Generated

DOI: 10.1186/s44315-025-00029-7

Keywords: Schizochytrium, light stress, lipid biosynthesis, EPA, DHA, squalene, beta-carotene, astaxanthin, reactive oxygen species, transcriptomics, mevalonate pathway, marine biotechnology

Batten disease, also known as neuronal ceroid lipofuscinosis, refers to a family of inherited disorders in which waste materials accumulate inside lysosomes, the recycling compartments of the cell. The resulting buildup, particularly in neurons, leads to progressive vision loss, seizures, motor decline, and early death. More than a dozen genes have been linked to different forms of the disease, yet for many of the encoded proteins, including CLN8, the normal function has remained frustratingly vague. CLN8 was known to sit in the endoplasmic reticulum and to travel along an ER-to-Golgi recycling pathway, but what it actually did during those journeys was unclear.

The new work answers that question with striking specificity. Two independent lines of investigation converged on the same conclusion: CLN8 catalyzes the acyl-CoA-dependent acylation of glycerophosphoglycerol, a small phosphorylated glycerol backbone, to produce lysophosphatidylglycerol. That reaction is the committed first step in a pathway that ultimately generates bis(monoacylglycero)phosphate, or BMP, a lipid so structurally peculiar that it is found almost exclusively in late endosomes and lysosomes, where it makes up a substantial fraction of the internal membrane surfaces.

The stereochemical detail matters. BMP is one of the very few lipids in mammalian cells with an unusual sn-1:sn-1′ glycerophosphate configuration, the mirror image of the configuration found in nearly every other glycerophospholipid. Because standard phospholipases cannot easily degrade this reversed architecture, BMP is intrinsically resistant to breakdown, an ideal property for a lipid that must persist in the harsh, enzyme-dense interior of the lysosome. Demonstrating that CLN8 is a stereospecific acyltransferase means the protein does not merely participate vaguely in lipid traffic; it selects the correct substrate, transfers the correct fatty acid chain from acyl-CoA, and initiates the construction of this biologically distinctive molecule.

Why should the failure to make BMP cause a brain disease? The answer lies in the lysosome’s operating principles. Lysosomes degrade cellular debris, damaged organelles, and macromolecules through the action of acid hydrolases, and many of those hydrolases require a membrane environment that can accept and present lipidated cargo. BMP is indispensable for the formation of intraluminal vesicles within multivesicular bodies, the structures in which lipid and protein cargo are delivered to degradative enzymes. Without adequate BMP, the sorting and degradation of cargo falters, and undigested material begins to pile up, precisely the hallmark pathology of Batten disease.

The experimental logic behind the discovery illustrates the power of modern lipid biochemistry combined with genetics. Rather than inferring function from protein interactions or localization alone, the researchers directly tested whether CLN8-containing preparations could convert glycerophosphoglycerol into lysophosphatidylglycerol in an acyl-CoA-dependent manner. The activity tracked with CLN8, was lost when CLN8 was removed or inactivated, and was restored when functional CLN8 was reintroduced. Disease-associated mutations in the protein compromised the enzymatic output, tying the biochemistry directly to the clinical syndrome. Complementary studies reached the same enzymatic assignment from different starting points, giving the conclusion unusual robustness.

Placing CLN8 in the pathway also resolves a long-standing gap. Scientists had identified downstream enzymatic steps that convert lysophosphatidylglycerol into BMP, and they knew where BMP accumulated, but the enzyme that supplies the pathway’s first committed product had been elusive. Identifying CLN8 as the acyltransferase means the biosynthetic route from a simple glycerophosphate precursor to the lysosome’s signature lipid is now, in outline, complete. It also explains previous observations that cells lacking CLN8 show abnormalities in lysosomal lipid composition and in the morphology of late endocytic compartments.

There are broader implications for membrane biology as well. CLN8 belongs to a family of ER-associated proteins, several of which have been linked to lysosomal storage diseases, that shuttle between the endoplasmic reticulum and the Golgi apparatus. If CLN8 performs its acyltransferase function at the ER or in transit, lipid synthesis may be spatially coupled to the trafficking routes that supply the endolysosomal system. That would suggest a model in which the cell builds a degradative lipid at its manufacturing hub and ships it forward, with CLN8 acting both as enzyme and possibly as escort. Testing that model will be a central task for future work.

For patients and families, the discovery does not translate immediately into therapy, but it changes the landscape of what therapy could look like. If the primary defect in CLN8 disease is a shortfall of BMP, then interventions that restore BMP levels, supply downstream lipid intermediates, or enhance parallel pathways for lysosomal membrane remodeling become plausible strategies. Enzyme replacement is complicated by the fact that CLN8 is an integral membrane protein embedded in intracellular membranes, a notoriously difficult class of therapeutic target. Small molecules that boost residual CLN8 activity, chaperone misfolded variants, or bypass the blocked step chemically are the kinds of approaches the new mechanistic understanding now makes testable.

The study also adds momentum to a growing realization that many so-called storage diseases are, at their core, diseases of lipid metabolism. As genome-encoded enzymes of lipid synthesis and remodeling continue to be matched with the disorders that arise when they fail, the field moves closer to a unified map connecting genes, membranes, and cellular decline. For CLN8, the journey from a disease gene of unknown purpose to a defined stereospecific acyltransferase is a striking example of that progress, and a reminder that even the most opaque proteins eventually surrender their function to patient biochemical scrutiny.

Subject of Research: Enzymatic function of the Batten disease protein CLN8 in bis(monoacylglycero)phosphate lipid biosynthesis

Article Title: The Batten disease protein CLN8 is a stereospecific acyltransferase in bis(monoacylglycero)phosphate biosynthesis

Article References: Sheokand, P. K., Lacabanne, D., James, A. M., Della Vecchia, S., Ruprecht, J. J., van der Kleij, J., Turner, K., Müller-Niva, J., Salo, M. H., Jenkins, B., Leese, S. K., Juneja, N., Yu, C. S., Booth, C. D., King, M. S., Uusimaa, J., Weimer, J. M., Koulman, A., Hinttala, R., … Petkevicius, K. (2026). The Batten disease protein CLN8 is a stereospecific acyltransferase in bis(monoacylglycero)phosphate biosynthesis. Nature Cell Biology. https://doi.org/10.1038/s41556-026-02061-0

Image Credits: AI Generated

DOI: 10.1038/s41556-026-02061-0

Keywords: Batten disease, CLN8, lysosomal storage disorders, bis(monoacylglycero)phosphate, lipid biosynthesis, acyltransferase, endoplasmic reticulum, lysosome, neuronal ceroid lipofuscinosis, lipid metabolism, glycerophosphoglycerol, neurodegeneration